Slotegraaf Anne I, Kruizenga Hinke M, Gerards Marissa H G, Verburg Arie C, Hoogeboom Thomas J, de van der Schueren Marian A E
Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, The Netherlands.
Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Nutrition & Dietetics, Amsterdam Movement Sciences, Aging and Vitality, Amsterdam, The Netherlands.
Nutr Diet. 2025 Apr;82(2):172-185. doi: 10.1111/1747-0080.12905. Epub 2024 Oct 21.
To report the changes in nutritional status, nutrition-related complaints and risk of sarcopenia in individuals attending a primary care dietitian in the Netherlands after a COVID-19 infection.
The study was registered on the clinicaltrials.gov registry (NCT04735744). Nutritional status and nutrition-related complaints were assessed with the Patient-Generated Subjective Global Assessment Short Form and body composition measurements when possible. Risk of sarcopenia was assessed with the Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls questionnaire. Dietitians reported on treatment goals, content and volume of dietetic treatment. Descriptive statistics were used to describe the study population and outcomes at baseline and end of treatment. For continuous variables, paired samples t-tests were used to compare scores at the start and the end of dietetic treatment. For dichotomous variables. McNemar tests and Wilcoxon signed-rank tests were used to determine differences between the start and end of treatment.
A total of 222 participants were included [mean age 50 (SD 13), 58% female, 34% overweight, 40% obese]. Malnutrition risk decreased from 44% (medium risk) and 20% (high risk) to 29% and 12% by the end of treatment (p < 0.001). The risk of sarcopenia decreased from 31% to 22% (p < 0.001). There was an imbalance between fat-free mass and fat mass in about half of the participants. The most commonly reported nutrition-related complaints were fatigue, no appetite, the feeling of being full and changed or loss of taste. Median treatment duration was 21 weeks [interquartile range (IQR) 13-26] and 5 consultations (IQR 4-7). Most participants (46%) aimed to maintain weight, with others aiming to lose (14%) or gain (14%) weight. At the end of treatment, 57% had achieved the goals.
Significant improvements in nutritional status and risk of sarcopenia were observed after dietetic treatment in primary care, and most participants achieved the treatment goals. Nevertheless, nutrition-related complaints and the risk of malnutrition or sarcopenia remained prevalent.
报告荷兰初级保健营养师处就诊的个体在感染新冠病毒后营养状况、营养相关主诉及肌肉减少症风险的变化。
该研究已在clinicaltrials.gov注册(NCT04735744)。营养状况和营养相关主诉通过患者主观整体评定简表进行评估,并尽可能进行身体成分测量。肌肉减少症风险通过力量、行走辅助、从椅子上起身、爬楼梯和跌倒问卷进行评估。营养师报告治疗目标、饮食治疗的内容和量。描述性统计用于描述研究人群以及基线和治疗结束时的结果。对于连续变量,配对样本t检验用于比较饮食治疗开始和结束时的得分。对于二分变量,McNemar检验和Wilcoxon符号秩检验用于确定治疗开始和结束之间的差异。
共纳入222名参与者[平均年龄50岁(标准差13),58%为女性,34%超重,40%肥胖]。治疗结束时,营养不良风险从44%(中度风险)和20%(高度风险)降至29%和12%(p<0.001)。肌肉减少症风险从31%降至22%(p<0.001)。约一半参与者的去脂体重和脂肪量之间存在失衡。最常报告的营养相关主诉为疲劳、食欲不振、饱腹感、味觉改变或丧失。中位治疗持续时间为21周[四分位间距(IQR)13 - 26],共进行5次咨询(IQR 4 - 7)。大多数参与者(46%)旨在维持体重,其他参与者旨在减重(14%)或增重(14%)。治疗结束时,57%的参与者实现了目标。
初级保健中饮食治疗后,营养状况和肌肉减少症风险有显著改善,且大多数参与者实现了治疗目标。然而,营养相关主诉以及营养不良或肌肉减少症风险仍然普遍存在。